Jiangsu East-Mab Biomedical technology Co., Ltd. was established in 2016 and is a national hightech enterprise in China. The company focuses on the field of recombinant proteins, aiming to provide high quality industrial-grade raw materials, such as diagnostic proteins,GMP-grade cytokines,enzymes,and target proteins,for IVD and Biomedical clients.
The company has set up a Kg-production capacity base with a big GMP workshop in Nantong and a product application development platform in Suzhou, China. The total area is more than 10000 square meters equipped with various advanced production & detection instruments.
The company has established a leading platform for the development of recombinant proteins, stable production processes, and a strict quality management system. The company has passed the ISO9001:2015/ ISO14001:2015/ ISO45001:2018,and is currently applying for ISO13485 system certification.
East Mab has nearly 100 employees, most of whom have a biomedical background. Some key team members are senior experts in the development of therapeutic antibody drugs/ biopharmaceutical products. They have a deep understanding of the structure and function of recombinant proteins and adhere to high standards of quality control requirements to ensure product quality and stability.
In 2021, The company has successfully raised millions of dollars from several well-known investment companies in China.